ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
6.37
-0.26 (-3.92%)
At close: Mar 13, 2026, 4:00 PM EDT
6.49
+0.12 (1.88%)
After-hours: Mar 13, 2026, 4:04 PM EDT
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $57.62 million as of March 13, 2026. Its market cap has increased by 20.86% in one year.
Market Cap
57.62M
Enterprise Value
67.34M
1-Year Change
20.86%
Ranking
Category
Stock Price
$6.37
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $57.62M, an increase of 2,792.67%. That is a compound annual growth rate of 10.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 57.62M | 3.58% |
| Dec 31, 2025 | 55.63M | 21.22% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mereo BioPharma Group | 61.42M |
| eXoZymes | 61.23M |
| TScan Therapeutics | 59.75M |
| Actuate Therapeutics | 59.50M |
| Cingulate | 58.72M |
| Entera Bio | 58.24M |
| MindWalk Holdings | 57.90M |
| Instil Bio | 56.02M |